Ameritas Investment Partners’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.7K | Hold |
982
| – | – | ﹤0.01% | 2674 |
|
|
2025
Q4 | $18.4K | Sell |
982
-430
| -30% | -$6.49K | ﹤0.01% | 2670 |
|
|
2025
Q3 | $18K | Hold |
1,412
| – | – | ﹤0.01% | 2703 |
|
|
2025
Q2 | $23.7K | Hold |
1,412
| – | – | ﹤0.01% | 2581 |
|
|
2025
Q1 | $18.1K | Hold |
1,412
| – | – | ﹤0.01% | 2597 |
|
|
2024
Q4 | $24.9K | Hold |
1,412
| – | – | ﹤0.01% | 2538 |
|
|
2024
Q3 | $32.3K | Hold |
1,412
| – | – | ﹤0.01% | 2420 |
|
|
2024
Q2 | $32.4K | Hold |
1,412
| – | – | ﹤0.01% | 2376 |
|
|
2024
Q1 | $55.9K | Hold |
1,412
| – | – | ﹤0.01% | 2080 |
|
|
2023
Q4 | $55.9K | Hold |
1,412
| – | – | ﹤0.01% | 2110 |
|
|
2023
Q3 | $62.6K | Buy |
1,412
+220
| +18% | +$9.6K | ﹤0.01% | 1961 |
|
|
2023
Q2 | $51.9K | Hold |
1,192
| – | – | ﹤0.01% | 2032 |
|
|
2023
Q1 | $51.9K | Hold |
1,192
| – | – | ﹤0.01% | 1958 |
|
|
2022
Q4 | $52.8K | Hold |
1,192
| – | – | ﹤0.01% | 2015 |
|
|
2022
Q3 | $47K | Hold |
1,192
| – | – | ﹤0.01% | 2026 |
|
|
2022
Q2 | $45K | Hold |
1,192
| – | – | ﹤0.01% | 2056 |
|
|
2022
Q1 | $47K | Hold |
1,192
| – | – | ﹤0.01% | 2096 |
|
|
2021
Q4 | $49K | Hold |
1,192
| – | – | ﹤0.01% | 2146 |
|
|
2021
Q3 | $50K | Hold |
1,192
| – | – | ﹤0.01% | 2155 |
|
|
2021
Q2 | $55K | Hold |
1,192
| – | – | ﹤0.01% | 2115 |
|
|
2021
Q1 | $56K | Hold |
1,192
| – | – | ﹤0.01% | 2020 |
|
|
2020
Q4 | $51K | Hold |
1,192
| – | – | ﹤0.01% | 1985 |
|
|
2020
Q3 | $59K | Hold |
1,192
| – | – | ﹤0.01% | 1738 |
|
|
2020
Q2 | $69K | Buy |
1,192
+159
| +15% | +$8.4K | ﹤0.01% | 1636 |
|
|
2020
Q1 | $47K | Hold |
1,033
| – | – | ﹤0.01% | 1689 |
|
|
2019
Q4 | $68K | Hold |
1,033
| – | – | ﹤0.01% | 1732 |
|
|
2019
Q3 | $60K | Hold |
1,033
| – | – | ﹤0.01% | 1780 |
|
|
2019
Q2 | $59K | Buy |
1,033
+328
| +47% | +$15.2K | ﹤0.01% | 1826 |
|
|
2019
Q1 | $27K | Hold |
705
| – | – | ﹤0.01% | 2227 |
|
|
2018
Q4 | $27K | Hold |
705
| – | – | ﹤0.01% | 2162 |
|
|
2018
Q3 | $27K | Buy |
705
+24
| +4% | +$910 | ﹤0.01% | 2355 |
|
|
2018
Q2 | $25K | Hold |
681
| – | – | ﹤0.01% | 2385 |
|
|
2018
Q1 | $20K | Hold |
681
| – | – | ﹤0.01% | 2421 |
|
|
2017
Q4 | $25K | Hold |
681
| – | – | ﹤0.01% | 2330 |
|
|
2017
Q3 | $21K | Hold |
681
| – | – | ﹤0.01% | 2391 |
|
|
2017
Q2 | $18K | Hold |
681
| – | – | ﹤0.01% | 2522 |
|
|
2017
Q1 | $13K | Buy |
+681
| New | +$12.6K | ﹤0.01% | 2604 |
|
Other funds holding NRC
VCM
QI
Ameritas Investment Partners's NRC Position: Q1 2026 in Review
Ameritas Investment Partners held its NRC Health Common Stock (NRC) position steady in Q1 2026 at 982 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2674.
Ameritas Investment Partners first reported a position in NRC in Q1 2017 and has held it in 37 quarters since. The position peaked at $69K in Q2 2020. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- Ameritas Investment Partners held 982 shares of NRC Health Common Stock worth $16.7K as of Q1 2026.
- Ameritas Investment Partners left its NRC Health Common Stock share count unchanged in Q1 2026.
- NRC Health Common Stock made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2674 holding.
- Ameritas Investment Partners first reported a position in NRC Health Common Stock in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's NRC Health Common Stock position peaked at $69K in Q2 2020.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.